Expand CTNM Menu
CTNM MENU

CTNM Stock Posts


Unusual Option Volume

CTNM Contineum Therapeutics8.20-0.36 (-4.3%)

Contineum Therapeutics trades 3,632 contracts.
Unusual Option Volume

CTNM Contineum Therapeutics9.26-4.12 (-30.8%)

Contineum Therapeutics trades 5,609 contracts.
Unusual Option Volume

CTNM Contineum Therapeutics13.04+0.48 (+3.8%)

Contineum Therapeutics trades 2,652 contracts.
Unusual Option Volume

CTNM Contineum Therapeutics13.35-1.47 (-9.9%)

Contineum Therapeutics trades 6,033 contracts. The company has the following event: 2026 Morgan Stanley Global Healthcare Conference on Sep 15, 2026. News: Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder
CTNM #ContineumTherapeutics stock declines -3.8% in after hours trading. See the latest news.

After Hours Decliner

CTNM Contineum Therapeutics14.820.000.0%

After Hours:14.25-0.57 (-3.9%)

Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder

Business WireMon, 14-Sep 4:05 PM

Unusual Option Volume

CTNM Contineum Therapeutics16.59-0.98 (-5.6%)

Contineum Therapeutics trades 7,002 contracts. The company has the following event: 2026 Morgan Stanley Global Healthcare Conference on Sep 15, 2026.
Market Data Delayed 15 Minutes